BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17698105)

  • 1. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
    Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
    Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
    Holmäng S; Johansson SL
    Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
    Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
    J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ
    Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.
    Schned AR; Andrew AS; Marsit CJ; Kelsey KT; Zens MS; Karagas MR
    Scand J Urol Nephrol; 2008; 42(3):237-42. PubMed ID: 18432530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.
    Cheng L; Neumann RM; Nehra A; Spotts BE; Weaver AL; Bostwick DG
    Cancer; 2000 Apr; 88(7):1663-70. PubMed ID: 10738225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?
    Gontero P; Gillo A; Fiorito C; Oderda M; Pacchioni D; Casetta G; Peraldo F; Zitella A; Tizzani A; Ricceri F
    Urol Int; 2014; 92(2):136-42. PubMed ID: 24080613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and progression in low grade papillary urothelial tumors.
    Holmäng S; Hedelin H; Anderström C; Holmberg E; Busch C; Johansson SL
    J Urol; 1999 Sep; 162(3 Pt 1):702-7. PubMed ID: 10458347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.